Telmisartan Inhibits TNFα-Induced Leukocyte Adhesion by Blocking ICAM-1 Expression in Astroglial Cells but Not in Endothelial Cells |
Jang, Changhwan
(Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University)
Kim, Jungjin (Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University) Kwon, Youngsun (Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University) Jo, Sangmee A. (Department of Nanobiomedical Science & BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University) |
1 | Benicky, J., Sanchez-Lemus, E., Honda, M., Pang, T., Orecna, M., Wang, J., Leng, Y., Chuang, D. and Saavedra, J. M. (2011) Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology 36, 857-870. DOI |
2 | Benson, S. C., Pershadsinggh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A. and Kurtz, T. W. (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective -modulating activity. Hypertension 43, 993-1002. DOI |
3 | Camacho, I. E., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D. and De Strooper, B. (2004) Peroxiosome proliferator-activated receptor induces a clearance mechanism for the amyloid- peptide. J. Neurosci. 24, 10908-10917. DOI |
4 | Choi, G. Y., Yoon, S. S., Kim, S. E. and Jo, S. A. (2017) KDM4B histone demethylase and G9a regulate expression of vascular adhesion proteins in cerebral microvessels. Sci. Rep. 7, 45005. DOI |
5 | Cianchetti, S., Fiorentino, A. D., Colognato, R., Stefano, R. D., Franzoni, F. and Pedrinelli, R. (2008) Anti-inflammatory and antioxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 198, 22-28. DOI |
6 | Daneman, R., Zhou, L., Kebede, A. A. and Barres, B. A. (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566. DOI |
7 | Davies, N. M., Kehoe, P. G., Ben-Shiomo, Y. and Martin, R. M. (2011) Association of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias. J. Alzheimers Dis. 26, 699-708. DOI |
8 | Bell, R. D., Winker, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R. and Zlokovic, B. V. (2010) Pericytes control key neurovascular functions and neuronal phenotype in adult brain and during brain aging. Neuron 68, 409-427. DOI |
9 | Erdo, F., Denes, L. and de Lange, E. (2017) Age-associated physiological and pathological changes at the blood-brain barrier: a review. J. Cereb. Blood Flow Metab. 37, 4-24. DOI |
10 | Hinz, M. and Scheidereit, C. (2014) The kinase complex in regulation and beyond. EMBO Rep. 15, 46-61. DOI |
11 | Janelidze, S., Mattsson, N., Stomrud, E., Lindberg, O., Palmqvist, S., Zetterberg, H., Blennow, K. and Hansson, O. (2018) CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease. Neurology 91, e867-e877. DOI |
12 | Kuldo, J. M., Westra, J., Asgeirsdóttir, S. A., Kok, R. J. and Oosterhuis, K. (2005) Differential effects of and p38 MAPK inhibitors and combinations thereof on and IL--induced proinflammatory status of endothelial cells in vitro. Am. J. Physiol. Cell Physiol. 289, C1229-C1239. DOI |
13 | Lanz, T. V., Ding, Z., Ho, P. P., Luo, J., Agrawal, A. N., Srinagesh, H., Axtell, R., Zhang, H., Platten, M., Wyss-Coray, T. and Steinman, L. (2010) Angiotensin II sustains brain inflammation in mice via TGF-beta. J. Clin. Invest. 120, 2782-2794. DOI |
14 | Lawson, C. and Wolf, S. (2009) ICAM-1 signaling in endothelial cells. Pharmacol. Rep. 61, 22-32. DOI |
15 | Lee, S. J. and Benveniste, E. N. (1999) Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 98, 77-88. DOI |
16 | Elkahloun, A. G., Rodriguez, Y., Alaiyed, S., Wenzel, E. and Saavedra, J. M. (2018) Telmisartan protects a microglia cell line from LPS injury beyond AT1 receptor blockade or activation. Mol. Neurobiol. 56, 3193-3210. DOI |
17 | Ponath, G., Park, C. and Pitt, D. (2018) The role of astrocytes in Multiple sclerosis. Front. Immunol. 9, 217. DOI |
18 | Li, N. C., Lee, A. C., Whitmer, R. A., Kivipelto, M., Lawler, E., Kazis, L. E. and Wolozin, B. (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340, b5465. DOI |
19 | Miyoshi, M., Miyano, K., Moriyama, N., Tangiguchi, M. and Watanabe, T. (2008) Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation. Eur. J. Neurosci. 27, 343-351. DOI |
20 | Ohshima, K., Mogi, M. and Horiuchi, M. (2013) Therapeutic approach for neuronal disease by regulating renin-angiotensin system. Curr. Hypertens. Rev. 9, 99-107. DOI |
21 | Roebuck, K. A. and Finnegan, A. (1999) Regulation of intercellular adhesion molecules-1 (CD54) gene expression. J. Leukoc. Biol. 66, 876-888. DOI |
22 | Saavedra, J. M. (2012) Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin. Sci. 123, 567-590. DOI |
23 | Saavedra, J. M., Benicky, J. and Zhou, J. (2006) Angiotensin II: multitasking in the brain. J. Hypertens. Suppl. 24, S131-S137. DOI |
24 | Lee, S. J., Drabik, K., Van Wagoner, N. J., Lee, S. J., Choi, C., Dong, Y. and Benveniste, E. N. (2000) ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J. Immunol. 165, 4658-4666. DOI |
25 | Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R. and Zlokovic, B. V. (2019) Blood-brain barrier: from physiology to disease and back. Physiol. Rev. 99, 21-78. DOI |
26 | Verbeek, M. M., Otte-Holler, I., Westphal, J. R., Wesseling, P., Ruiter, D. J. and de Waal, R. M. (1994) Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease. Am. J. Pathol. 144, 104-116. |
27 | Torika, N., Asraf, K., Danon, A., Apte, R. N. and Fleisher-Berkovich, S. (2016) Telmisartan modulates glial activation: in vitro and in vivo studies. PLoS ONE 11, e0155823. DOI |
28 | Torika, N., Asraf, K., Cohen, H. and Fleisher-Berkovich, S. (2017) Intranasal telmisartan ameliorates brain pathology in five familial Alzheimer's disease mice. Brain Behav. Immun. 64, 80-90. DOI |
29 | Tsukuda, K., Mogi, M., Iwanami, J., Min, L. J., Sakata, A., Jing, F., Iawi, M. and Horiuchi, M. (2009) Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 54, 782-787. DOI |
30 | Villapol, S. and Saavedra, J. M. (2015b) Neuroprotective effects of angiotensin receptor blockers. Am. J. Hypertens. 28, 289-299. DOI |
31 | Wang, J., Ho, L., Chen, L., Zhao, Z., Zhao, W., Qian, X., Humala, N., Seror, I., Bartholomew, S., Rosendorff, C. and Pasinetti, G. M. (2007) Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J. Clin. Invest. 117, 3393-3402. DOI |
32 | Song, K. H., Park, J. H., Jo, I., Park, J. Y., Seo, J., Kim, S. A. and Cho, D. H. (2016) Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in -stimulated endothelial cells by inhibiting expression. Vasc. Pharmacol. 78, 43-52. DOI |
33 | Wang, Y., Cao, J., Fan, Y., Xie, Y., Xu, Z., Yin, Z., Gao, L. and Wang, C. (2016) Artemisinin inhibits monocyte adhesion to HUVECs through the and MAPK pathways in vitro. Int. J. Mol. Med. 37, 1567-1575. DOI |
34 | Winker, E. A., Sengillo, J. D., Bell, R. D., Wang, J. and Zlokovic, B. V. (2012) Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J. Cereb. Blood Flow Metab. 32, 1841-1852. DOI |
35 | Xu, Y., Xu, Y., Wang, Y., Wang, Y., He, L., Jiang, Z., Huang, Z., Liao, H., Li, J., Saavedra, J. M., Zhang, L. and Pang, T. (2015) Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via -dependent AMPK activation. Brain Behav. Immun. 50, 298-313. DOI |